PeptideTDB

Marine peptides for blood pressure & vessels

Some peptides from fish are claimed to lower blood pressure by blocking an enzyme (ACE) that tightens blood vessels. The human trials are few and small, and they tested different products.

What the evidence shows

Valyl-tyrosine, a defined sardine-derived peptide

Limited human evidence

One small randomised trial (29 people, 4 weeks) found blood pressure fell by roughly 9 mm Hg systolic and 5 mm Hg diastolic against no change on placebo, with blood markers consistent with ACE inhibition. Nothing else in this hub replicates it.

Marine collagen peptides added to usual care in type 2 diabetes with hypertension

Limited human evidence

One randomised trial in 100 patients found lower diastolic and mean arterial pressure plus better blood sugar and cholesterol over three months. Patients stayed on their usual medicines, and the abstract gives no dose.

Fish protein hydrolysate and blood-vessel function in healthy adults

Limited human evidence

A single 20 g dose in nine people did not improve endothelium-dependent dilation, while whey hydrolysate did. It says nothing about blood pressure or longer use.

Verdicts reflect only the studies summarised on this site, last reviewed November 9, 2026. See how verdicts are set.

Studies (3)

StudyDesignPeptide
Oliveira et al., 2020Human trial (controlled)Fish protein hydrolysate
Zhu et al., 2010Human trial (controlled)Marine (fish-derived) collagen peptides
Kawasaki et al., 2000Human trial (controlled)Valyl-tyrosine (sardine peptide)
Human trial (controlled)Blood pressure & vesselsFish protein hydrolysateOral

Effects of fish protein hydrolysate ingestion on endothelial function compared to whey protein hydrolysate in humans

Oliveira et al., 2020 · Int J Food Sci Nutr · 9 healthy adults

Whey protein hydrolysate increased endothelium-dependent dilation of a blood vessel 30 minutes after the dose compared with placebo. Fish protein hydrolysate did not. In a lab assay the fish product had higher total antioxidant capacity than the whey product.

What it found and what it doesn't show

Human trial (controlled)Blood pressure & vesselsMarine (fish-derived) collagen peptidesOral

Therapeutic effects of marine collagen peptides on Chinese patients with type 2 diabetes mellitus and primary hypertension

Zhu et al., 2010 · Am J Med Sci · 100 patients with type 2 diabetes and primary hypertension (50 per group) plus 50 healthy comparison subjects, in China

Compared with patient controls, the marine collagen peptide group had lower fasting blood glucose, HbA1c, diastolic blood pressure, mean arterial pressure, triglycerides, total and LDL cholesterol and creatinine, and higher HDL cholesterol and insulin…

What it found and what it doesn't show

Human trial (controlled)Blood pressure & vesselsValyl-tyrosine (sardine peptide)Oral

Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects

Kawasaki et al., 2000 · J Hum Hypertens · 29 adults with high-normal blood pressure or mild hypertension

On the sardine peptide, systolic and diastolic blood pressure fell by 9.7 and 5.3 mm Hg after one week and by 9.3 and 5.2 mm Hg after four weeks (P < 0.001), with no change on placebo. Pressure crept back up during the recovery period. Blood markers fitted…

What it found and what it doesn't show

Not covered yet

  • No large or long randomised trial of a marine peptide supplement for blood pressure is summarised here.
  • The hub does not yet cover the animal and laboratory work on ACE-inhibitory fish peptides.

Educational information only. It is not medical or legal advice, and nothing here is a recommendation to use any peptide. Talk to a clinician before starting a supplement or treatment.